Using nanoparticles to enhance radiation treatment for brain tumors in children
Intrathecal delivery of radiation sensitizing nanoparticles in pediatric neuro-oncology
This study is testing a new way to help kids with brain tumors by using tiny particles filled with medicine that are delivered directly into the fluid around their brain and spine, hoping to make the treatment more effective and improve their health.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Univ of Massachusetts Med Sch Worcester NIH-funded |
| Lab location | 1 site (Worcester, United States) |
| Project ID | NIH-10653853 on NIH RePORTER |
What this research studies
This research investigates a new method of delivering radiation sensitizing nanoparticles directly into the cerebrospinal fluid of pediatric patients with brain tumors. By encapsulating a specific drug within biodegradable nanoparticles, the goal is to improve the effectiveness of treatment for leptomeningeal metastasis, a condition where cancer spreads to the membranes surrounding the brain and spinal cord. The approach aims to enhance drug retention and penetration in the affected areas, potentially leading to better outcomes for young patients. The study will involve administering these nanoparticles intrathecally to assess their distribution and impact on tumor growth in a controlled setting.
Who could benefit from this research
Good fit: Ideal candidates for this research are children aged 0-21 who have been diagnosed with primary malignant brain tumors and exhibit leptomeningeal metastasis.
Not a fit: Patients with brain tumors that have not metastasized to the leptomeninges or those who are older than 21 may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective treatments for children with aggressive brain tumors, improving survival rates and reducing radiation-related damage.
How similar studies have performed: While the approach of using nanoparticles for drug delivery is gaining traction, this specific application in pediatric neuro-oncology is relatively novel and has not been extensively tested in prior studies.
Where this research is happening
Worcester, United States
- Univ of Massachusetts Med Sch Worcester — Worcester, United States (Active)
Researchers
- Principal investigator: Sirianni, Rachael W — Univ of Massachusetts Med Sch Worcester
- Study coordinator: Sirianni, Rachael W
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.